{"date":"2025-08-15","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2025-08-15-2224-1x98est","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-15","time":"22:24:49","subject":"公告本公司114年7月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-15 22:24，「公告本公司114年7月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-15-2224-87qz4w","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-15","time":"22:24:17","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-15 22:24，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-15-1854-10lp9v3","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-15","time":"18:54:56","subject":"公告本公司調整現金股利之配息率","clause":"第14款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-15 18:54，「公告本公司調整現金股利之配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-08-15-1810-1lhzzrd","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-15","time":"18:10:25","subject":"公告本公司114年第一次現金增資基準日暨相關事宜(補充代收股款及存儲專戶行庫)","clause":"第9款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-08-15 18:10，「公告本公司114年第一次現金增資基準日暨相關事宜(補充代收股款及存儲專戶行庫)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-08-15-1726-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-08-15","time":"17:26:55","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-08-15 17:26，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-08-15-1724-1jxw0pw","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-08-15","time":"17:24:23","subject":"公告修正本公司113年度年報部分內容","clause":"第51款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-08-15 17:24，「公告修正本公司113年度年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-08-15-1716-16mtvkx","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-15","time":"17:16:38","subject":"更正本公司113年第四季iXBRL申報資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-08-15 17:16，「更正本公司113年第四季iXBRL申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-08-15-1707-8bm9h6","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-08-15","time":"17:07:37","subject":"本公司法人董事辭任","clause":"第6款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-08-15 17:07，「本公司法人董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-08-15-1633-1f6cmaj","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-08-15","time":"16:33:19","subject":"代重要子公司富康活力醫藥(股)公司公告董事會決議現金增資發行新股","clause":"第11款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-08-15 16:33，「代重要子公司富康活力醫藥(股)公司公告董事會決議現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-08-15-1618-1gceexp","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-08-15","time":"16:18:03","subject":"公告本公司更換主辦輔導券商","clause":"第44款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-08-15 16:18，「公告本公司更換主辦輔導券商」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-15-1541-1qxnh13","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-15","time":"15:41:49","subject":"本公司第七次買回公司股份期間屆滿及執行狀況","clause":"第35款","fact_date":"2025-08-17","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-15 15:41，「本公司第七次買回公司股份期間屆滿及執行狀況」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2025-08-15-1540-gue8dc","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2025-08-15","time":"15:40:29","subject":"本公司代重要子公司StemCyte, Inc. (美國永生公司)公告向美國食品藥物管理局(US FDA)提出REGENECYTE治療長新冠症候群三期臨床試驗(樞紐試驗)申請","clause":"第44款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2025-08-15 15:40，「本公司代重要子公司StemCyte, Inc. (美國永生公司)公告向美國食品藥物管理局(US FDA)提出REGENE」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-08-15-1537-1jvmgo8","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-08-15","time":"15:37:06","subject":"補充公告本公司董事會通過藥用軟袋生產設備投資案(採購訂單簽約金額)","clause":"第20款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-08-15 15:37，「補充公告本公司董事會通過藥用軟袋生產設備投資案(採購訂單簽約金額)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-08-15-1506-195ez6s","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-08-15","time":"15:06:05","subject":"公告本公司「COMPOSITION FOR ENHANCING COGNITIVEABILITIES AND USE THEREOF一種用於提升認知能力之組合物及其用途」取得新加坡發明專利","clause":"第44款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-08-15 15:06，「公告本公司「COMPOSITION FOR ENHANCING COGNITIVEABILITIES AND USE T」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-08-15-1504-1nh19i8","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-08-15","time":"15:04:57","subject":"公告本公司控股子公司FBD Biologics Limited依約收到上海復宏漢霖生物技術股份有限公司支付第一階段HCB101新藥授權簽約金400萬美元","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-08-15 15:04，「公告本公司控股子公司FBD Biologics Limited依約收到上海復宏漢霖生物技術股份有限公司支付第一階段HCB」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-08-15-1452-1muo30n","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-08-15","time":"14:52:08","subject":"公告本公司辦理股票初次上櫃過額配售內容","clause":"第44款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-08-15 14:52，「公告本公司辦理股票初次上櫃過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-15-1434-znej1m","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-15","time":"14:34:28","subject":"本公司受邀參加 Morgan Stanley舉辦之Taiwan Discovery Forum","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-15 14:34，「本公司受邀參加 Morgan Stanley舉辦之Taiwan Discovery Forum」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-08-15-1212-twg8gd","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-08-15","time":"12:12:03","subject":"更正本公司114年第二季個別財務報告之iXBRL部份內容","clause":"第44款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-08-15 12:12，「更正本公司114年第二季個別財務報告之iXBRL部份內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-08-15-1114-1fqkmsr","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-08-15","time":"11:14:55","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-08-15 11:14，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}